$TG

GOTTWALD WILLIAM M sold $284K of TG (indirect holdings)

GOTTWALD WILLIAM M sold 35,506 indirectly-held shares of TREDEGAR CORP (TG) at $8.00 ($0.28M total) on 2026-10-16.

Original reporting
SEC EDGAR · GOTTWALD WILLIAM M
Published Oct 20, 2026, 4:56 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 5:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TG
Bearish
medium confidence
Mentioned
$TG
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TGBearishLow
01

Why it matters

The insider sale may prompt short‑term price weakness, but without other catalysts the effect is likely limited.

02

Market read

Primary relevance is to TG shareholders; broader market impact is negligible.

03

What to watch

No accompanying news on earnings, product milestones, or regulatory events that would contextualize the sale.

Relevance 4/10Novelty 4/10Timing: post-filing today

Background

SEC Form 4 filings disclose insider transactions; a 10% owner selling shares is noteworthy but not uncommon.

Company-level read

Ticker impact

$TGBearishMedium confidence
Context

Form 4 shows a 10% owner sold 35,506 shares of Tredegar Corp for $284,048, reducing his stake to 325,620 shares.

Expected impact

likely downward pressure as the market prices in the insider sell

Evidence & confidence

The sale is relatively small in dollar terms (< $1M) but involves a 10% owner, which can influence sentiment.

Market effects

Minimal impact on the biotech sector; the sale is company‑specific.

No broader regional effect.

Limited to Tredegar investors.

Counterpoint

The sale could be routine portfolio rebalancing, not a negative signal.

Key entities

  • Tredegar Corp

    Biotech firm (ticker TG) subject of the insider sale.

  • Gottwald William M

    10% owner and insider who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TGMed

Tredegar Soars on Q2 Financials

Tredegar Corp (NYSE:TG) reported Q2 2026 results for the period ended June 30, 2026. Net income from continuing operations rose to $6.0 million, or $0.17 per diluted share, from $1.8 million, or $0.05 per share, in Q2 2025. Excluding special items, net income was $6.4 million, or $0.18 per share. Aluminum Extrusions EBITDA was $14.5 million versus $9.3 million in Q2 2025.

$TGMed

TREDEGAR REPORTS SECOND QUARTER 2026 RESULTS

TREDEGAR CORP (TG) filed an SEC Form 8-K — Results of Operations and Financial Condition. TREDEGAR REPORTS SECOND QUARTER 2026 RESULTS • Increased second quarter 2026 results, with net income from continuing operations of $6.0 million, or $0.17 per diluted share, for the second quarter of 2026 compared to $1.8 million, or $0.05 per diluted share, for the second quarte

$DOLELow

Pale Fire Capital SE (Senkypl Dusan, Barta Jan) purchased $8.6M of DOLE (indirect holdings)

Pale Fire Capital SE purchased 648,356 indirectly-held shares of Dole plc (DOLE) at an average of $13.19 ($13.12–$13.39, $8.55M total) across 3 trades over 2026-10-20 to 2026-10-22. Filed jointly with Pale Fire Capital SICAV a.s. (10% owner), Pale Fire Capital investicni spolecnost a.s. (10% owner), Senkypl Dusan (10% owner) and Barta Jan (10% owner).